Information Provided By: 
Fly News Breaks for March 4, 2019
ACHC
Mar 4, 2019 | 11:14 EDT
Jefferies analyst Brian Tanquilut said the articulation from Acadia Healthcare management of the bridge from Q4 earnings to 2019 EBITDA guidance underscored the achievability, and possibly even conservatism, of the company's outlook. Additionally, the company's strategic review of the U.K. segment provides a potential positive catalyst in the near-term, said Tanquilut, who has a Buy rating and $40 price target on Acadia shares.
News For ACHC From the Last 2 Days
